Inhibrx Biosciences, Inc. INBX Common stock, capital shares reserved for future issuance
Common stock, capital shares reserved for future issuance at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s common stock, capital shares reserved for future issuance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s common stock, capital shares reserved for future issuance?
- Inhibrx Biosciences, Inc. (INBX) reported common stock, capital shares reserved for future issuance of $5.02M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s common stock, capital shares reserved for future issuance changed year-over-year?
- Inhibrx Biosciences, Inc.'s common stock, capital shares reserved for future issuance decreased by 2.1% year-over-year, from $5.13M to $5.02M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s common stock, capital shares reserved for future issuance?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s common stock, capital shares reserved for future issuance has grown at a -39.0% compound annual growth rate (CAGR), from $13.79M to $5.13M.